What is Rythm?
Rythm is at the forefront of neurotechnology, dedicated to enhancing human health and well-being by revolutionizing the comprehension of the brain. The company boasts a distinguished team comprising global authorities in sleep medicine, neuroscience, engineering, machine learning, design, and advanced computing. Rythm's pioneering product, Dreem, an active wearable device engineered to elevate sleep quality, was initially introduced through a limited series in 2016. Operating from Paris and San Francisco, Rythm fosters close collaborations with leading research institutions and hospitals to harness the full potential of neuroscience. The company has garnered considerable investment, including grants and awards, to fuel its world-class team of over 70 professionals.
How much funding has Rythm raised?
Rythm has raised a total of $11M across 1 funding round:
Unspecified
$11M
Unspecified (2016): $11M, investors not publicly disclosed
What's next for Rythm?
With a major enterprise-level funding context and a recent strategic investment, Rythm is poised for significant scaling and further innovation in neurotechnology. The substantial backing indicates a transition from early-stage development towards broader market penetration and the expansion of its research initiatives. Future endeavors will likely focus on leveraging its expertise in sleep medicine and machine learning to develop next-generation brain-understanding solutions, potentially exploring new therapeutic applications and enhancing the capabilities of its wearable technology. The company's strategic partnerships with research institutes and hospitals will be crucial in validating and advancing its scientific discoveries.
See full Rythm company page
